AI in Hepatology
About
In an era of rapid technological advancement, harnessing the power of artificial intelligence (AI) has become paramount in revolutionising healthcare. Within hepatology, AI presents an invaluable opportunity to transform the landscape of diagnosis, treatment, and understanding of liver disease. With its capacity to analyse vast amounts of data swiftly and accurately, AI offers the potential to uncover novel scientific insights, improve diagnostic accuracy, and personalise patient care by predicting response to treatments. It also has an exciting role in transforming the way educational content is put together and delivered. Although there are several advantages to the utilisation of AI, it is incumbent on us to become knowledgeable of associated potential pitfalls and harm and how to utilise these tools responsibly.
Meet the Task Force
Aim
The AI Task Force is comprised of experts in the field and is designed to shape the association`s approach to AI for the benefit of members and the wider hepatology community including patients and the general public.
The AI Task Force aims to advise the EASL Governing Board in a number of key strategic areas:
- Research: Advancing large-scale, collaborative research initiatives among the hepatology community, with a particular emphasis on navigating data-sharing challenges and appropriate use of AI.
- Education: Developing innovative AI-driven tools and platforms to transform learning experiences for researchers, physicians, allied health professionals, patients, policy makers and the public.
- Clinical decision making: Provide guidance on leveraging AI algorithms to assist healthcare professionals in diagnosis and patient management, integrating insights from all relevant stakeholders to enhance the decision-making process.
- EASL Congress and other events: Exploring ways to integrate AI for enhanced content delivery and event optimisation.
- EASL Journals: Ensuring the quality of AI-related research and topics.
- Industry Collaboration: Forming strategic partnerships to drive AI advancements relevant to liver diseases.
- Operational: Work with technical service providers and the EASL Office team to enhance business efficiency and customer service.
Explore the resources tailored to you
Position paper on AI
AI in Hepatology Resources on EASL Campus
Discover the opportunities available for you
Excellence in Liver Care Award
The EASL Emerging Leader Award is an annual award, dedicated specifically to young fellows. Every year, the EASL Governing Board and Young Investigators Task Force select two YI Awardees, based on their international liver research achievements.
Membership
EASL supports Young Investigators by helping them attend EASL meetings. We offer two types of bursaries to the presenting authors only of the best accepted abstracts who are aged 35 or younger and/or are still in training.
Become a member
Unlock the full potential of being part of the EASL
community. As a member, you’ll gain access to
exclusive resources, reduced event fees, top-tier
journals, and professional development opportunities designed to support your career in hepatology
Quotes
“Embarking on a leadership journey at EASL empowers you to drive innovation, shape the future of hepatology, and inspire the next generation—an opportunity for personal growth, collaboration, and lasting impact.”
Alternative Name
Leadership at EASL
“Embarking on a leadership journey at EASL empowers you to drive innovation, shape the future of hepatology, and inspire the next generation—an opportunity for personal growth, collaboration, and lasting impact.”
Debbie Shawcross, EASL Secretary General 2025-2026
